Accident News For Attorneys, the Legal Field & the Public
Fosamax is a drug marketed by Merck & Co. and it is their trade name for the generic formulation of alendronic acid or alendronate sodium, a biophosphonate used to treat osteoporosis and other bone diseases. According to the pharmaceutical litigation attorneys at Bisnar and Chase, Merck lost the patent on alendronate sodium in 2008, despite a series of attempts to have the patent extended and prevent generic marketing of the drug. Today, several generic versions of this drug are also available, primarily from Barr and Teva Pharmeceuticals. Fosamax and Fosamax+D, which includes Vitamin D in the formulation, are designed to inhibit osteoclast-mediated bone resorption.
In simpler terms, Fosamax and its generics allow sufferers of osteoporosis to build stronger bones and theoretically prevent weakness or breakage by preventing loss of bone tissue. However, there is some doubt that this is actually what occurs throughout the body given some of the negative side effects of Fosamax use.
Studies soon showed that there were some serious side effects associated with the use of Fosamax. Twenty-three cases of esophageal cancer were reported by the New England Journal of Medicine in 2008 that were believed to be connected to Fosamax use. Some patients also experienced an onset or increase in severity of TMJ, or tempromandibular joint disorder, especially after oral surgery. However, the far greater concern was the development of low-impact femoral fractures in a number of patients.
Low-impact fractures occur when a bone simply “snaps” while standing or walking. In the case of Fosamax, long-term users were reported to have a much higher incidence of low-impact fractures than non-users. While standing or walking, many patients have had thigh bones simply break for no apparent reason other than a jolt or push that would not normally result in a broken bone. Further investigation revealed that the cause of these low-impact fractures may be the relationship between Fosamax use and the development of brittle thigh bones, or femurs.
In 2010, the Food and Drug Administration issued a warning about Fosamax use and its implication for low-impact fractures. However, the FDA has not recalled Fosamax, nor has it issued any further warnings about possible side effects and complications.
You should talk to your doctor right away if you experience pain in the legs, jaw, or any other part of the body, or if you are having stomach problems; these can be signs of serious complications from Fosamax use. Always consult your doctor before stopping or beginning any medication; if you have concerns about Fosamax or a generic version of the drug, talk to your doctor immediately.
If you have suffered a serious injury or illness as the result of Fosamax use, you may be entitled to compensation for your medical bills, as well as your pain and suffering and other costs. In order to find out, it is in your best interest to speak with a Bisnar and Chase Fosamax lawyer in California. It is very important to talk to a personal injury attorney if you have been taking Fosamax, as many symptoms take a long time to develop, and long-term injury or bone deterioration can be quite severe. Call 866-990-7887 to take advantage of their no obligation consultation for free.
© 2013 Personal Injury Lawyer Journal
Published by BISNAR | CHASE